<SEC-DOCUMENT>0001513162-21-000116.txt : 20210930
<SEC-HEADER>0001513162-21-000116.hdr.sgml : 20210930
<ACCEPTANCE-DATETIME>20210930170354
ACCESSION NUMBER:		0001513162-21-000116
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210930
ITEM INFORMATION:		Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
FILED AS OF DATE:		20210930
DATE AS OF CHANGE:		20210930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37863
		FILM NUMBER:		211295686

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head> <title>Form 8-K</title></head> <body lang=EN-IN> <div style=page:WordSection1> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US><br>UNITED STATES</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>WASHINGTON, D.C.</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>FORM 8-K</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>CURRENT REPORT</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Pursuant to Section 13 or 15(d) of the</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Securities Exchange Act of 1934</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Date of Report (date of earliest event reported):&nbsp;<b>September 29, 2021</b></font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>BIOMERICA, INC.</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>(Exact Name of Registrant as Specified in its Charter)</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <div align=center> <table width=700 bordercolor=transparent style="WIDTH:525pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:13pt> <td width=232 style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:174pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><a name=Form_8_K><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Delaware</font></a></p></td> <td width=232 style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:174pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>001-37863</font></p></td> <td width=232 style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:174pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>95-2645573</font></p></td></tr> <tr style=HEIGHT:26pt> <td width=232 style="HEIGHT:26pt; WIDTH:174pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"' lang=EN-US>(State or Other<br>Jurisdiction of<br>Incorporation)</font></p></td> <td width=232 style="HEIGHT:26pt; WIDTH:174pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"' lang=EN-US>(Commission</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"' lang=EN-US>File Number)</font></p></td> <td width=232 style="HEIGHT:26pt; WIDTH:174pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"' lang=EN-US>(IRS Employer</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"' lang=EN-US>Identification No.)</font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>17571 Von Karman Ave.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Irvine, California 92614</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>(Address of Principal Executive Offices</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Including Zip Code)</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>949-645-2111</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>(Registrant&#146;s Telephone Number,</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Including Area Code)</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Not applicable</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>(Former Name or Former Address if Changed</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Since Last Report)</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:12pt 0cm 0pt; LINE-HEIGHT:normal'><font style="FONT-FAMILY:Wingdings; COLOR:black" lang=EN-US>o</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>&nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style="FONT-FAMILY:Wingdings; COLOR:black" lang=EN-US>o</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>&nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style="FONT-FAMILY:Wingdings; COLOR:black" lang=EN-US>o</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>&nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style="FONT-FAMILY:Wingdings; COLOR:black" lang=EN-US>o</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:14.4pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:3pt 0cm 0pt; LINE-HEIGHT:14.4pt'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Securities registered pursuant to Section 12(b) of the Act:<br>&nbsp;</font></p> <div align=center> <table width=700 bordercolor=transparent style="WIDTH:525pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:14pt> <td width=235 style="HEIGHT:14pt; WIDTH:176pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><b><u><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Title of each class</font></u></b></p></td> <td width=92 style="HEIGHT:14pt; WIDTH:69pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><b><u><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Trading Symbol</font></u></b></p></td> <td width=356 style="HEIGHT:14pt; WIDTH:267pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><b><u><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Name of each exchange on which registered</font></u></b></p></td></tr> <tr style=HEIGHT:14pt> <td width=235 style="HEIGHT:14pt; WIDTH:176pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Common Stock, par value $0.08</font></p></td> <td width=92 style="HEIGHT:14pt; WIDTH:69pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>BMRA</font></p></td> <td width=356 style="HEIGHT:14pt; WIDTH:267pt; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:2pt 0cm; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>NASDAQ Capital Market</font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; ; LINE-HEIGHT:14.4pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; ; LINE-HEIGHT:14.4pt' align=justify><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&nbsp;&nbsp; Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="FONT-SIZE:12pt; FONT-FAMILY:Wingdings; COLOR:black" lang=EN-US>&#168;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; ; LINE-HEIGHT:14.4pt' align=justify><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;</font><font style="FONT-SIZE:12pt; FONT-FAMILY:Wingdings; COLOR:black" lang=EN-US>&#168;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>1</font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><b><font lang=EN-US>Item 4.02, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>Biomerica, Inc. (the &#147;Company&#148;) has determined that the calculation and expense of non-cash stock-based compensation, related to issued stock options, as reported in the consolidated financial statements of the Company, have been materially &nbsp;understated based on the application of accounting principles generally accepted in the United States. The Company has historically reported stock-based compensation expenses on the dates of vesting, rather than recognizing the expense ratably over the vesting period. The Company has also used an incorrect method for calculating forfeiture estimate for issued stock options. Stock-based compensation expense shown on the statement of operations is a non-cash expense which impacts accumulated deficit (losses) and additional paid-in capital on the balance sheet. However, this does not impact the Company&#146;s cash, revenues or other aspects of ongoing operations. &nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>These non-cash stock-based compensation expense errors were identified by management during the implementation of a new accounting stock option software system. To confirm these findings, the Company&#146;s Audit Committee retained a third-party accounting advisory firm, to work with management and the Company&#146;s independent registered public accounting audit firm, PKF San Diego, LLP (PKF), to determine the degree by which the Company&#146;s historical financial statements were impacted. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>This review has found no indication that these errors were the result of an override of controls or from misconduct at the Company. The Company&#146;s stock-based expense calculation methodology and the actual reported expense each year had been fully disclosed to, and reviewed by PKF, as part of their annual audits. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>As a result of this review process, on September 29, 2021, the Audit Committee and management, in consultation with PKF and legal counsel, have determined that the Company&#146;s prior audited consolidated financial statements and the related audit report included in the Company&#146;s Annual Report on Form 10-K for the fiscal year ended May 31, 2021, as well as the Company&#146;s interim consolidated financial statements included in the Company&#146;s Quarterly Reports on Form 10-Q for the periods ended August 31, 2020, November 30, 2020 and February 28, 2021 should no longer be relied upon. As soon as possible, the Company intends to file an amended Annual Report on Form 10-K for the year ended May 31, 2021, to correct the impacted financial statements. The Company also intends to restate the above referenced fiscal year 2021 quarterly period consolidated financial statements when they are included in Quarterly Reports on Form 10-Q for the comparable periods in fiscal year 2022.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>As such, the Company anticipates the following adjustments to its fiscal 2021 Form 10-K:</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0cm 36pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:; TEXT-INDENT:-18pt'><a name=_Hlk83811452><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>for fiscal year-ended 2021, an additional non-cash expense of </font></a><a name=_Hlk83386128 /><a name=_Hlk83636323 /><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>$900,000 to $1,100,000</font><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>, increasing net losses for the year from ($6,469,036) to between ($7,369,000) and ($7,569,000), <a name=_Hlk83811558>and increasing accumulated deficit (losses) and paid-in capital each by </a>$900,000 to $1,100,000; and </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; MARGIN:0cm 0cm 0cm 36pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0cm 36pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:; TEXT-INDENT:-18pt'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>for fiscal year-ended 2020, an additional non-cash expense of <a name=_Hlk83636393>$300,000 to $390,000</a>, increasing net losses for the year from ($2,339,054) to between ($2,640,000) and ($2,730,000), and increasing accumulated deficit (losses) and paid-in capital each by $300,000 to $390,000. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>The Company also <a name=_Hlk83630706>anticipates </a>that in order to adjust for incorrectly reported non-cash stock-based compensation expense in years prior to fiscal year 2020, it will make a one-time adjustment to its consolidated balance sheet for fiscal year-ended May 31, 2019, of $750,000 to $950,000. This adjustment will increase accumulated deficit (losses) from <a name=_Hlk83386256>($19,587,678) to between ($20,337,000) and ($20,537,000) </a>and will increase additional paid-in capital from $22,830,006 to between $23,580,000 to $23,780,000 for the fiscal year ended May 31, 2019. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri",sans-serif; TEXT-ALIGN:justify; MARGIN:0cm; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT",serif' lang=EN-US>While it is anticipated that these corrective actions will be adequate, the Company intends to seek guidance from the Office of the Chief Accountant and Division of Corporation Finance at the U.S.&nbsp;Securities and Exchange Commission, to determine if other disclosures or changes in the Company&#146;s historical financial statements may be necessary to accurately report these corrections. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:' align=center><font style='FONT-FAMILY:"TimesNewRomanPSMT","serif"' lang=EN-US>Forward-Looking Statements</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'><font style='FONT-FAMILY:"TimesNewRomanPSMT","serif"' lang=EN-US>Except for the statements of historical fact contained herein, the information presented in this Current Report on Form 8-K constitutes &#147;forward-looking statements&#148; as such term is used in applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as &#147;plans&#148;, &#147;expects&#148;, &#147;is expected&#148;, &#147;budget&#148;, &#147;potential&#148;, &#147;scheduled&#148;, &#147;estimates&#148;, &#147;forecasts&#148;, &#147;intends&#148;, &#147;anticipates&#148;, &#147;believes&#148;, or &#147;projects&#148;, or the negatives thereof or variations of such words and phrases or statements that certain actions, events or results &#147;will&#148;, &#147;should&#148;, &#147;may&#148;, &#147;could&#148;, &#147;would&#148;, &#147;might&#148; or &#147;will be taken&#148;, &#147;occur&#148; or &#147;be achieved&#148; or the negative of these terms or comparable terminology. Forward-looking statements include statements regarding the Company&#146;s intent to restate its prior financial statements and the estimated adjustments of the restated financials. There can be no assurance that the Company&#146;s management, audit committee or independent registered public accounting firm will not reach conclusions regarding the impact of the restatement that are different from management&#146;s preliminary estimates or identify additional issues or other considerations in connection with the restatement and the audit and review process or that these issues will not require additional adjustments to the Company&#146;s prior financial results. All of these statements are subject to risks and uncertainties which may cause actual results to differ materially from those stated here. These risks and uncertainties include, but are not limited to, the risk that additional information may arise from the oversight of the audit committee, the risk that the process of preparing and auditing the financial statements or other subsequent events would require the Company to make additional adjustments, the time and effort required to complete the restatement of the financial reports, the ramifications of the Company&#146;s potential inability to timely file required reports, the risk of identifying weaknesses in the Company&#146;s internal controls over financial reporting or the Company&#146;s ability to remediate such material weaknesses, the risk of litigation or governmental investigations or proceedings relating to such matters, and the risk of any potential adverse effects on the Company&#146;s business, results of operations, financial condition and stock price as a result of the restatement and correction process.&nbsp;&nbsp; Other risks are described more fully in the Company&#146;s filings with the Securities and Exchange Commission. Any such forward-looking statements are expressly qualified in their entirety by these cautionary statements. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking statements. The forward-looking statements included in this Current Report on Form 8-K are made as of the date of this Current Report on Form 8-K and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>2</font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>SIGNATURE</font></u></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>&nbsp;&nbsp;&nbsp;&nbsp; Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal' align=center>&nbsp;</p> <table width=600 bordercolor=transparent style="WIDTH:450pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><a name=T13><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Dated:&nbsp; September 30, 2021</font></a></p></td> <td width=47% colspan=2 nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Biomerica, Inc.</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /></tr> <tr style=HEIGHT:15pt> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>By:</font></p></td> <td width=47% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:47%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; BORDER-LEFT:0px; PADDING-RIGHT:0cm" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>/s/&nbsp;Zackary S. Irani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Zackary S. Irani</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=50% nowrap style="HEIGHT:15pt; WIDTH:50%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom /> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47%; PADDING-BOTTOM:0cm; PADDING-TOP:0cm; PADDING-LEFT:0cm; PADDING-RIGHT:0cm" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>Chief Executive Officer</font></p></td></tr></table> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0cm 21.6pt 0pt 0cm; LINE-HEIGHT:normal'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0cm 0cm 0pt; LINE-HEIGHT:normal' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black' lang=EN-US>3</font></p></div></body>
<!-- EDGAR Validation Code: 87BA0B1D -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
